Efficacy, Safety and Tolerability of Agomelatine in the Treatment of Major Depressive Disorder

PHASE3CompletedINTERVENTIONAL
Enrollment

503

Participants

Timeline

Start Date

December 31, 2006

Primary Completion Date

January 31, 2008

Conditions
Major Depressive Disorder (MDD)
Interventions
DRUG

agomelatine

DRUG

placebo

Trial Locations (51)

10021

Novartis Investigative Site, New York

10023

Novartis Investigative Site, New York

10312

Novartis Investigative Site, Staten Island

11201

Novartis Investigative Site, Brooklyn

11366

Novartis Investigative Site, Fresh Meadows

11516

Novartis Investigative Site, Cedarhurst

19104

Novartis Investigative Site, Philadelphia

21061

Novartis Investigative Site, Glen Burnie

22201

Novartis Investigative Site, Arlington

27609

Novartis Investigative Site, Raleigh

30080

Novartis Investigative Site, Smyrna

30328

Novartis Investigative Site, Atlanta

32124

Novartis Investigative Site, Daytona Beach

32806

Novartis Investigative Site, Orlando

33143

Novartis Investigative Site, Miami

33161

Novartis Investigative Site, North Miami

33319

Novartis Investigative Site, Fort Lauderdale

38119

Novartis Investigative Site, Memphis

43623

Novartis Investigative Site, Toledo

44122

Novartis Investigative Site, Cleveland

53227

Novartis Investigative Site, West Allis

Novartis Investigative Site, Milwaukee

60068

Novartis Investigative Site, Park Ridge

60076

Novartis Investigative Site, Skokie

60169

Novartis Investigative Site, Hoffman Estates

60194

Novartis Investigative Site, Hoffman Estates

66206

Novartis Investigative Site, Prairie Village

66606

Novartis Investigative Site, Topeka

67207

Novartis Investigative Site, Wichita

71103

Novartis Investigative Site, Shreveport

73103

Novartis Investigative Site, Oklahoma City

75062

Novartis Investigative Site, Irving

77008

Novartis Investigative Site, Houston

77090

Novartis Investigative Site, Houston

78756

Novartis Investigative Site, Austin

80212

Novartis Investigative Site, Denver

85210

Novartis Investigative Site, Mesa

89128

Novartis Investigative Site, Las Vegas

90024

Novartis Investigative Site, Los Angeles

92056

Novartis Investigative Site, Oceanside

92103

Novartis Investigative Site, San Diego

92108

Novartis Investigative Site, San Diego

92123

Novartis Investigative Site, San Diego

97210

Novartis Investigative Site, Portland

97504

Novartis Investigative Site, Medford

98004

Novartis Investigative Site, Bellevue

98104

Novartis Investigative Site, Seattle

Unknown

Novartis Investigative Site, North Miami

07033

Novartis Investigative Site, Kenilworth

07901

Novartis Investigative Site, Summit

08755

Novartis Investigative Site, Toms River

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Novartis

INDUSTRY